Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – Retropubic or transobturator placement of tension-free vaginal tape are both effective techniques for reducing stress urinary incontinence in women. However, leg or groin…
NEW YORK (Reuters Health) – New research from Japan suggests that antenatal corticosteroids promote survival in extremely preterm infants born at 22 to 23 weeks gestation. Based on…
NEW YORK (Reuters Health) – Clinical outcomes are no better or worse when nulliparous women with an unfavorable cervix at term have elective induction of labor compared to…
NEW YORK (Reuters Health) – Wound complications occur twice as often when transverse cesarean sections are closed with staples rather than subcuticular sutures, the results of a meta-analysis…
NEW YORK (Reuters Health) – Methylene blue has certain advantages over isosulfan blue in sentinel lymph node procedures, but the risk of a palpable mass at the injection…
NEW YORK (Reuters Health) – Women undergoing emetogenic surgical procedures are less likely to have postoperative nausea and vomiting when treated with ondansetron plus casopitant than with ondansetron…
NEW YORK (Reuters Health) – The majority of women who become pregnant after in vitro fertilization (IVF) receives progesterone throughout the first trimester, but that may not be…
NEW YORK (Reuters Health) – Among women treated for early, endocrine-responsive breast cancer, adjuvant therapy with the aromatase inhibitor letrozole leads to better overall survival than does tamoxifen,…
NEW YORK (Reuters Health) – Oral contraceptives are just as effective as a gonadotropin-releasing hormone (GnRH) agonist for relieving pelvic pain due to endometriosis, results of a small…
NEW YORK (Reuters Health) – For women with thyroid cancer treated with radioiodine-131, subsequent pregnancy is safe without adverse outcomes for the offspring. That’s according to a report…
